Post job

CTI Molecular Imaging CEO and executives

Executive Summary. Based on our data team's research, Ronald Nutt is the CTI Molecular Imaging's CEO. CTI Molecular Imaging has 500 employees, of which 1 are in a leadership position.
Work at CTI Molecular Imaging?
Share your experience

Rate CTI Molecular Imaging's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Ronald Nutt

CEO

Prior to founding ABT in 2006, Dr. Nutt co-founded CTI Molecular Imaging, Inc. in 1983. He was Vice President of Research and Development from 1983 through 1998 when he became the President of CTI PET Systems, a joint venture between Siemens and CTI. In 2002 he became the President and Chief Executive Officer of CTI Molecular Imaging, Inc. a NASDAQ public company. Dr. Nutt led the negotiations resulting in the sale of CTI to Siemens in 2005. As Vice President of R&D, Dr. Nutt had more than 30 patents in the field of molecular imaging, authored and co-authored a large number of technical publications and has presented invited talks at numerous conferences. Prior to founding CTI Molecular Imaging, Dr. Nutt was the co-founder of several other companies including Technology for Energy Corporation, Radio Systems Corporation and Delta M Corporation. Dr. Nutt was the Vice President of EG&G ORTEC during the time frame of 1969 through 1979 where he was responsible for developing many innovations in the field of nuclear physics instrumentation. Prior to ORTEC he was a researcher at the Oak Ridge National Laboratory and taught Electrical Engineering at the University of Tennessee. Dr. Nutt holds a BS, MS and PhD from the University of Tennessee and was awarded in 1997 the Dean Daugherty award for his outstanding achievements, the highest Engineering Alumni honors. Dr. Nutt is a Fellow of the IEEE and was named by the organization the Outstanding Engineering for the Eastern part of the US in 1999 for his contributions to molecular imaging. He was also awarded the Distinguished Scientist of the Year by the Academy of Molecular Imaging in year 1999.

Do you work at CTI Molecular Imaging?

Does leadership effectively guide CTI Molecular Imaging toward its goals?

CTI Molecular Imaging jobs

CTI Molecular Imaging founders

Name & TitleBio
Ronald Nutt

CEO

Prior to founding ABT in 2006, Dr. Nutt co-founded CTI Molecular Imaging, Inc. in 1983. He was Vice President of Research and Development from 1983 through 1998 when he became the President of CTI PET Systems, a joint venture between Siemens and CTI. In 2002 he became the President and Chief Executive Officer of CTI Molecular Imaging, Inc. a NASDAQ public company. Dr. Nutt led the negotiations resulting in the sale of CTI to Siemens in 2005. As Vice President of R&D, Dr. Nutt had more than 30 patents in the field of molecular imaging, authored and co-authored a large number of technical publications and has presented invited talks at numerous conferences. Prior to founding CTI Molecular Imaging, Dr. Nutt was the co-founder of several other companies including Technology for Energy Corporation, Radio Systems Corporation and Delta M Corporation. Dr. Nutt was the Vice President of EG&G ORTEC during the time frame of 1969 through 1979 where he was responsible for developing many innovations in the field of nuclear physics instrumentation. Prior to ORTEC he was a researcher at the Oak Ridge National Laboratory and taught Electrical Engineering at the University of Tennessee. Dr. Nutt holds a BS, MS and PhD from the University of Tennessee and was awarded in 1997 the Dean Daugherty award for his outstanding achievements, the highest Engineering Alumni honors. Dr. Nutt is a Fellow of the IEEE and was named by the organization the Outstanding Engineering for the Eastern part of the US in 1999 for his contributions to molecular imaging. He was also awarded the Distinguished Scientist of the Year by the Academy of Molecular Imaging in year 1999.

CTI Molecular Imaging executives FAQs

Zippia gives an in-depth look into the details of CTI Molecular Imaging, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CTI Molecular Imaging. The employee data is based on information from people who have self-reported their past or current employments at CTI Molecular Imaging. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CTI Molecular Imaging. The data presented on this page does not represent the view of CTI Molecular Imaging and its employees or that of Zippia.

CTI Molecular Imaging may also be known as or be related to CTI MOLECULAR IMAGING INC and CTI Molecular Imaging.